PubMed

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.

Katrak S, Gasasira A, Arinaitwe E, Kakuru A, Wanzira H, Bigira V, Sandison TG, Homsy J, Tappero JW, Kamya MR, Dorsey G.

Malar J. 2009 Nov 30;8(1):272. [Epub ahead of print]PMID: 19948038 [PubMed - as supplied by publisher]

Strategies to Optimize HIV Treatment Outcomes in Resource-Limited Settings.

Nakanjako D, Colebunders R, Coutinho AG, Kamya MR.

AIDS Rev. 2009 Oct-Dec;11(4):179-89.PMID: 19940945 [PubMed - in process]

Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable.

Wanyenze RK, Nawavvu C, Ouma J, Namale A, Colebunders R, Kamya MR.

Trop Med Int Health. 2009 Nov 3. [Epub ahead of print]PMID: 19891756 [PubMed - as supplied by publisher]Related articles

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.

Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, Dorsey G.

Clin Infect Dis. 2009 Dec 1;49(11):1629-37.PMID: 19877969 [PubMed - in process]Related articles

PHARMACOKINETICS OF ARTEMETHER-LUMEFANTRINE AND ARTESUNATE/AMODIAQUINE IN CHILDREN IN KAMPALA, UGANDA.

Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR, Aweeka F.

Antimicrob Agents Chemother. 2009 Oct 19. [Epub ahead of print]PMID: 19841149 [PubMed - as supplied by publisher]Related articles

Assessing the impact of indoor residual spraying on malaria morbidity using a sentinel site surveillance system in Western Uganda.

Bukirwa H, Yau V, Kigozi R, Filler S, Quick L, Lugemwa M, Dissanayake G, Kamya M, Wabwire-Mangen F, Dorsey G.

Am J Trop Med Hyg. 2009 Oct;81(4):611-4.PMID: 19815875 [PubMed - indexed for MEDLINE]Related articles

Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children.

Jensen TP, Bukirwa H, Njama-Meya D, Francis D, Kamya MR, Rosenthal PJ, Dorsey G.

Malar J. 2009 Sep 15;8:213.PMID: 19754955 [PubMed - indexed for MEDLINE]Related articlesFree article

Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.

Castelnuovo B, Manabe YC, Kiragga A, Kamya M, Easterbrook P, Kambugu A.

Clin Infect Dis. 2009 Sep 15;49(6):965-72.PMID: 19673615 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO.

BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.PMID: 19622553 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlates of unprotected receptive anal intercourse among gay and bisexual men: Kampala, Uganda.

Raymond HF, Kajubi P, Kamya MR, Rutherford GW, Mandel JS, McFarland W.

AIDS Behav. 2009 Aug;13(4):677-81. Epub 2009 Jun 3.PMID: 19495955 [PubMed - indexed for MEDLINE]Related articles

Interaction of malaria and HIV in Africa.

Reithinger R, Kamya MR, Whitty CJ, Dorsey G, Vermund SH.

BMJ. 2009 Jun 3;338:b2141. doi: 10.1136/bmj.b2141. No abstract available. PMID: 19493941 [PubMed - indexed for MEDLINE]Related articles

Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.

Staedke SG, Mwebaza N, Kamya MR, Clark TD, Dorsey G, Rosenthal PJ, Whitty CJ.

Lancet. 2009 May 9;373(9675):1623-31. Epub 2009 Apr 9.PMID: 19362361 [PubMed - indexed for MEDLINE]Related articles

Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?

Castelnuovo B, Nanyonjo A, Kamya M, Ocama P.

Afr Health Sci. 2008 Jun;8(2):133-4.PMID: 19357764 [PubMed - indexed for MEDLINE]Related articlesFree article

Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.

Baalwa J, Mayanja-Kizza H, Kamya MR, John L, Kambugu A, Colebunders R.

Afr Health Sci. 2008 Sep;8(3):190-5.PMID: 19357749 [PubMed - indexed for MEDLINE]Related articlesFree article

Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.

Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong JK, Cao H, Havlir D, Charlebois ED.

Clin Immunol. 2009 Jun;131(3):410-4. Epub 2009 Mar 19.PMID: 19303366 [PubMed - indexed for MEDLINE]Related articles

Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.

Greenhouse B, Slater M, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Clark TD, Staedke SG, Kamya MR, Hubbard A, Rosenthal PJ, Dorsey G.

J Infect Dis. 2009 Mar 1;199(5):758-65.PMID: 19199542 [PubMed - indexed for MEDLINE]Related articles

The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H.

AIDS Res Hum Retroviruses. 2009 Jan;25(1):65-71.PMID: 19182922 [PubMed - indexed for MEDLINE]Related articles

Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.

Castelnuovo B, John L, Lutwama F, Ronald A, Spacek LA, Bates M, Kamya MR, Colebunders R.

J Int Assoc Physicians AIDS Care (Chic Ill). 2009 Jan-Feb;8(1):52-9. Epub 2008 Dec 17.PMID: 19095630 [PubMed - indexed for MEDLINE]Related articles

Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance.

Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ.

AIDS Res Ther. 2008 Oct 28;5:23.PMID: 18957083 [PubMed]Related articlesFree article

Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.

Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO.

Malar J. 2008 Jun 11;7:107.PMID: 18547416 [PubMed - indexed for MEDLINE]Related articlesFree article